跳至主要内容
临床试验/CTRI/2024/03/063679
CTRI/2024/03/063679招募中2 期

A randomised open clinical trial to evaluate the efficacy of Thyroherb tablet in the management of primary hypothyroidism - nil

Pankajakasthuri Herbals India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either gender in the age group between 18 to65 years
  • 2.T3 less than 0.97 ng/mL or T4 less than 5.53 ng/mL or TSH greater than 4.049 ng/mL
  • 3.Patients eligible having Symptoms of Hypothyroidism with minimum 3-6 months duration
  • 4.Willing to enrol in study by signing Informed consent.

排除标准

  • 1.Earlier participation in similar clinical trials.
  • 2.Patients with secondary Hypothyroidism.
  • 3.Patients having other systemic diseases not under control.
  • 4.Patients who are not willing to sign the informed consent form
  • 5.Patients who are diagnosed with malignancies, autoimmune diseases, complications
  • of Hypothyroidism, Temporary hypothyroidism, acute onset disorders like Hashimoto’s Thyroiditis.
  • 6.Patients who have undergone any type of thyroid surgery.
  • 7.Patients who are on corticosteroid therapy.
  • 8.Subjects who are pregnant, breast feeding and those who plan to conceive within the trial period.
  • 9.Patients of special category population.
  • 10.Unable to respond properly for questionnaire or when a patient is too severely ill to answer the questions.

研究者

发起方
Pankajakasthuri Herbals India Pvt Ltd

相似试验